Acelity L.P. Inc.
Acelity L.P. Inc., a leading global medical technology company headquartered in the United States, specialises in advanced wound care and regenerative medicine. Founded in 1976, Acelity has established itself as a pioneer in the industry, focusing on innovative solutions that enhance patient outcomes. With a strong presence in North America, Europe, and Asia-Pacific, the company offers a diverse range of products, including advanced wound dressings and biologics. Acelity's unique offerings, such as the KCI brand of negative pressure wound therapy, set it apart in the competitive landscape. The company has achieved significant milestones, including numerous patents and awards for its cutting-edge technologies. As a trusted partner in healthcare, Acelity continues to lead the way in transforming wound care and improving the quality of life for patients worldwide.
DitchCarbon Score
How does Acelity L.P. Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Acelity L.P. Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Acelity L.P. Inc.'s reported carbon emissions
Acelity L.P. Inc., headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. In the absence of specific emissions data or commitments, it is important to note that Acelity L.P. Inc. may be operating within an industry context that increasingly prioritises sustainability and climate action. Many organisations in the healthcare and medical technology sectors are setting ambitious targets to reduce their carbon footprints and enhance their environmental performance. As Acelity L.P. Inc. continues to navigate its climate strategy, it may consider aligning with industry standards and frameworks, such as the Science Based Targets initiative (SBTi), to establish measurable and impactful climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Acelity L.P. Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
